Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

Organisation › Details

China (govt)

	Start	1998-07-14 existent
	Industry	pharmaceutical

	Region	China
	City	n. a.
		Address record changed: 2011-05-15

Basic data	Employees	n. a.


		Record changed: 2023-07-10

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for China (govt)

[1] Boehringer Ingelheim. (4/9/24). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Receives Approval for Supply of EU and US Markets". Ingelheim & Shanghai....
[2] ERS Genomics Ltd.. (3/26/24). "Press Release: Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual Property Administration". Dublin....
[3] Bayer AG. (4/13/22). "Press Release: Bayer Receives Approval for Precision Oncology Treatment Vitrakvi in China [Not intended for U.S. and UK Media]". Berlin....
[4] Bayer AG. (8/27/20). "Press Release: Bayer Receives Approval for Xofigo in China [Not intended for U.S. and UK Media]". Berlin....
[5] Merck KGaA. (3/2/20). "Press Release: Erbitux Approved for First-Line Use in China in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) [Not intended for UK-based media]". Darmstadt....
[6] BlueBee. (10/9/19). "Press Release: BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for its Genomics Data Platform". Rijskwijk....
[7] Novartis AG. (7/19/19). "Press Release: Novartis Key Multiple Sclerosis Product Gilenya Approved in China". Basel....
[8] Novartis AG. (4/2/19). "Press Release: Novartis First-in-class Cosentyx Approved in China for Psoriasis Patients". Basel....
[9] Merck KGaA. (11/6/18). "Press Release: Merck Debuts at First China International Import Expo". Shanghai....
[10] Roche. (8/20/18). "Press Release: China National Drug Administration Grants Rapid Approval of Roche’s Alecensa (alectinib) as a Treatment for ALK-positive Lung Cancer". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]